Skip to main content

Peer Review reports

From: Clinical characteristics of middle-aged and older patients with MS treated with interferon beta-1b: post-hoc analysis of a 2-year, prospective, international, observational study

Original Submission
1 Mar 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
9 May 2021 Reviewed Reviewer Report
1 Jun 2021 Reviewed Reviewer Report
28 Jun 2021 Author responded Author comments - Francesco Patti
Resubmission - Version 3
28 Jun 2021 Submitted Manuscript version 3
6 Jul 2021 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
28 Jul 2021 Editorially accepted
23 Aug 2021 Article published 10.1186/s12883-021-02347-w

You can find further information about peer review here.

Back to article page